IDEXX LABORATORIES INC /DE — Director's Dealing 2013

Feb 19, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-14

Reporting Person: POLEWACZYK JAMES F (Corporate Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-14	Common Stock	M	186	—	Acquired	6287	Direct
2013-02-14	Common Stock	M	194	—	Acquired	6481	Direct
2013-02-14	Common Stock	M	281	—	Acquired	6762	Direct
2013-02-14	Common Stock	M	400	—	Acquired	7162	Direct
2013-02-14	Common Stock	M	257	—	Acquired	7419	Direct
2013-02-14	Common Stock	F	464	$91.68	Disposed	6955	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-14	Non-Qualified Stock Option (right to buy)	$91.68	A	8222	Acquired	2020-02-13	Common Stock (8222)	Direct
2013-02-14	Incentive Stock Option (right to buy)	$91.68	A	1090	Acquired	2020-02-13	Common Stock (1090)	Direct
2013-02-14	Restricted Stock Unit	$	A	900	Acquired		Common Stock (900)	Direct
2013-02-14	Restricted Stock Unit	$	M	186	Disposed		Common Stock (186)	Direct
2013-02-14	Restricted Stock Unit	$	M	194	Disposed		Common Stock (194)	Direct
2013-02-14	Restricted Stock Unit	$	M	281	Disposed		Common Stock (281)	Direct
2013-02-14	Restricted Stock Unit	$	M	400	Disposed		Common Stock (400)	Direct
2013-02-14	Restricted Stock Unit	$	M	257	Disposed		Common Stock (257)	Direct

Footnotes

F1: Includes 45 shares and 55 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2012 and 12/31/2012, respectively.

F2: Grant of options to buy shares of common stock becomes exercisable as to 1,863 shares on 02/14/2014 and 02/14/2015, 1,862 shares on 02/14/2016 and 02/14/2017, and the remaining 772 shares on 02/14/2018.

F3: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2018) of the grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F9: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.